Washington D.C. 20549

                            Report of Foreign Issuer

                      Pursuant to Rule 13a-16 or 15d-16 of
                       the Securities Exchange Act of 1934

                        For period ending March 19, 2008

                               GlaxoSmithKline plc
                              (Name of registrant)

               980 Great West Road, Brentford, Middlesex, TW8 9GS
                    (Address of principal executive offices)

             Indicate by check mark whether the registrant files or
                 will file annual reports under cover Form 20-F
                                  or Form 40-F

                              Form 20-F x Form 40-F

         Indicate by check mark whether the registrant by furnishing the
        information contained in this Form is also thereby furnishing the
       information to the Commission pursuant to Rule 12g3-2(b) under the
                        Securities Exchange Act of 1934.

                                    Yes No x

   Notice of Annual General Meeting, 2007 Annual Report & 2007 Annual Review

GlaxoSmithKline plc issued its Notice of Annual General Meeting at 2.00pm (UK)
today, 19 March 2008.

The Company's Annual General Meeting will be held at 2.30pm on Wednesday 21 May
2008 at the Queen Elizabeth II Conference Centre, Broad Sanctuary, Westminster,
London SW1P 3EE.

Copies of the Company's Notice of Annual General Meeting, together with the 2007
Annual Report and 2007 Annual Review have been submitted to the UK Listing
Authority, and will shortly be available for inspection at the UK Listing
Authority's Document Viewing Facility which is situated at:

The Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
Tel: +44 (0) 20 7066 1000

These documents can also be viewed on the Company's website at

S M Bicknell
Company Secretary

19 March 2008


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorised.

                                                             GlaxoSmithKline plc

Date: March 19, 2008                                          By: VICTORIA WHYTE
                                                              Victoria Whyte
                                                 Authorised Signatory for and on
                                                   behalf of GlaxoSmithKline plc